Member Info for Porky9

@BagMann

Yes I did, and I still stand by it...

Stella is a perfectly qualified NED and brings a certain set of skills to the board. We need other NEDs with DIFFERENT skill sets but for what she brings to the board She is VERY experienced and knows what’s she’s talking about.

She is NOT investing currently because as she stated the business is not yet established enough for the stock to be stable.

She is no idiot, she is not going to buy at 7p to lose money knowing full well a placing is due anytime soon and that’s IF they can get it over the line in the current market conditions it will probably be sub 5p at best. I suspect she might support the next placing IF they can raise enough cash to get them to break even and help get the deal over the line. Hopefully she will.

The only reason why you dislike her is because she was honest. Yes, her wording could have been more subtle I agree, yes the way it was delivered was not a great way to encourage outside investor buying BUT you can’t escape the fact that what she said was totally 100% correct.

Why you are picking on Stella is beyond me? Kevin had a £17.5k bonus, he didn’t spend any of that on shares? Suzy earns over £160k a year, frankly more than I suspect a number of small investors here backing this operation, she didn’t buy either, in fact none of them! So why single out Stella?

Anyone remember that Talent show on TV where if you didn’t like the ACT or their performance you could vote them off and as the votes built up a long stick with a hook on the end would come from the right of the screen and drag them off?

I think we need something like that for the next AGM, with them all lined up, once you have enough lame ass excuses from one of them you vote and in comes the hook :)

The Suzy Blush’o’Meter that currently indicates how uncomfortable the question is by her degree of redness is due an upgrade:)

Won’t change anything but would certainly make future AGMs more entertaining!

Point 4 - correct - it’s NOT going to be easy, it will take time

1. This is NOT a echo chamber, people are free to contribute, you can agree/disagree post contra argument as you see fit. Size of holding not relevant. ALL shareholders irrespective of size can comment. The board needs to listen to feedback good or bad, it doesn’t have to act on that feedback if it chooses not to. Simples.

2. IMO, others can disagree but one thing the business does not lack is scientific expertise. In fact I would say it’s top heavy as it is.. Firstly we already have Suzy, Cathy, Zai and other recent additions, not to mention the support of the Uni Spin out team/ partner in the pipeline for eg CLX. The business is weak commercially from a business aspect both in fiscal control and general commercial acumen. A poor director does not wake the next morning and become a good one. The board needs bolstering replacements made.

3. Adam does NOT need to be a scientific advisor he needs to join the Board as a Director, bring his CEO experience and work to find experienced execs to join the board that add value. Guide them not to make blundering errors, draw a line under THX and get 201 in with a funded biotech that can get trials going if not come clean with SH regarding the true position if it’s now not good enough?

4. The lab, the lab. Jesus, the lab. We are now supporting them by default to build a CRO fine. It wasn’t the focus of our original investment but it is now. This will take time and a significant amount of cash in sales and marketing to win orders to go from zero to £2.5m of invoices contracts for the business to break even assuming all other overheads don’t get any higher. The market is full of CROs hence why they want Buy and Build and be a transformative CRO to have USPs to compete in the space. They were scheduled to add contracts from 2024, if they get something in early with the recent acquisition great but it’s not going to take time.

5. They need to sort out the placing in this H2 ideally sooner than later to avoid a VERY discounted placing if it’s left until a few weeks before money runs out. That’s business. Further you can only place at what the market will support.

6. What News? @PM2022? You have been telling us news tomorrow for the last two years. The business can only update when it has something to say. IMO the next news will be either a) them finally waking up and realising THX can’t get funded and Pulling them from 201 or b) details of the placing. If they can get a sizeable lab contract in early, fine that would be a positive. BUT nothing anytime soon is going to a) bring significant cash in or b) increase your mcap from £7m to £50m in an instance as you claim. That’s utter BS.

As it stands the ONLY hope of a material cash injection is from a) placing cash providing they can get support for it or b) if THX pay the £1.3 due which would certainly contribute to the overheads / cash burn but I put that at ZERO chance.

Pork’s

Tried to refrain from posting whilst you battle it out

The bottom line is that Nick has had his own differences with me, he blocked me on twitter but it matters not, he is a shrewd investor and I respect that. PM2022 on the other hand has been a continual ramping poster at every opportunity without any evidence to back up his claims.

Now the position with Adam frankly is a bloody farce and I will tell you why. IF he is NOT a director and is simply an advisor to the board, they cannot share critical information with him, they can’t tell him we need to do x with 201 or Y is coming, what do you think? Because if they did and he sold shares that would be insider dealing and carry a prison stretch hence both parties need to be careful regarding what they do and don’t discuss with each other, frankly he needs to join the board end of.

But worse than that, Adams votes saved certain board members when they needed to go. They have all retained their positions, it’s bloody ridiculous so we will now do the same things and expect a different outcome. Frankly I’m disappointed with that decision and I would like Adam to explain why he thought that a good move?

Now they need to sort the raise out at best price, sort and draw a line under THX, get spending back under control, Suzy is NOT fit for CEO sorry, she needs to head Sciences end of and a CEO appointed that can negotiate at top table and get deals done. I would also like the board to give their bonuses back, it won’t happen but the company can’t afford them and I don’t see why shareholders should get diluted in raises just to give them bonuses they haven't earned.

Meanwhile, sorry but also the current mcap is bloated especially with 201 hanging as it is so it’s going to get very interesting to see if they can get the raise away at anything close to 5p - time will tell.

Good luck - ultimately Adam will either take a proper position on the board or possibly sell the lot out and buy the key assets in a liquidation and merge them into his own business, frankly the latter is what I would do - the current BOD are not fit to advance this business in their current format IMO

The ramping club will try and make you believe anything...

On L2 the House Broker CNKS are at 5.5p and only two brokers will take stock off you at 7p, if you are selling a larger position certainly better to do it in small sells and hopefully others or those down averaging will buy into them.

Market not impressed because we need board changes not more of the same. Adam was in an advisory position before. He needs to be a Director to make changes. Also, some conclusi9n on 201 needs to happen.

Frankly, if I was Adam, I would take control of my own destiny, sell my entire holding and offer to buy /reverse CLX and 201 into my own lab business and let VAL continue without him. Then he can look for own support to fund trials.

Good luck, see what next week brings....

Oh an advisory role, wow that will really change the fundamentals here.

He had an advisory role before but they pulled that after a short period.

He needs to be a DIRECTOR on the board to make any meaningful changes otherwise its business as usual raise/spend/raise/spend/consolidate

I still don't know why he voted to keep Gerry, Martin and Kevin on the board, a golden opportunity to really change things for the good missed.

Ramping crew here desperate to cling onto any positive ramp going, lets see how the market reacts and what the placing comes in at, should it secure support.

Amazing...

@PM2022

There is NO cash to middle of 2024 that is a bloody lie, STOP peddling that dream.

Prior to the acquisition they had cash to Feb 24 then lights out

With the acquisition they have until circa the end of the year

You don’t leave a placing until the last moment otherwise you risk it being 1 or 2p not to mention good staff leaving due to an uncertain future not to mention client confidence if you are looking to win lab contracts. If they issue now they have a chance at 5p and in this market they will want to take it.

The chances of THX getting any cash to them in H2 are minimal and this is why Stella is not yet buying because the stock is unstable.

And don’t quote “nothing to gain from a single digit placing” they can ONLY raise at what the market will support and they need the cash IF they can secure support - as it stands that will be a challenge in this market.

And if Adam wanted to join the board he just needs to put up a resolution. Clearly he doesn’t at the moment.

I am actually wondering if you are a plant to try and pump the price whilst someone else offloads? Nobody can be so deluded?

@PM2022

FFS - I don’t know how you have the balls to return here and go straight in with a full on ramp, Jeeze and I thought I was good at ramping, you are world class mate.

If I could write in Red against all your ramping points I would but let’s just kill the first one. With the recent additional costs they need the placement before the year end, fact. If they don’t, the small window to place at 5p will go and you will be looking at a materially lower placing price.

They can always issue more shares I guess and do another consolidation event but by default or otherwise you are now investing in a start up CRO business that will need significantly more time and cash to get to its destination. The board wanted Buy and Build initially so that they could make the CRO a tCRO and have USPS to stand out from the crowd, there are a vast number of competitors in this space. This is going to take time.

So stop posting that this is a quick win, it’s a long term play, end of. Your post is simply amazing

Yes, and likely need another 7m in funding at this rate to get this start up lab to get anywhere near breakeven. Also, have you actually researched how many CRO competitors there are in the U.K.? That’s why Buy and Build is essential to create USPS.

Satu also referenced the trials stopping and the patients update/data, yes that was 2020 pre Kevin’s appointment but Martin and Gerry were on the board and Suzy did work there so not a totally blameless answer. And anyway, I would argue cash burn is now back up to where it was previously anyhow.

Business mcap materially higher than it was in April 21, it was £2.25m back then, today it’s nearly four times higher and in my opinion the business represents a higher risk profile, for one thing you are all investing by default or otherwise in a start up CRO that will take time and more money to establish.

As for Adam and Suzy’s comment about “useful on the sciences” he is MD of his own business for crying out loud and knows far more than Suzy, I simply don’t get why Adam is supporting this current board set it? It makes no sense, how Gerry specifically survived the vote is beyond me - I would love for Adam to post here to say why?

And if the business is not stable enough for Stella to buy shares, whilst I totally understand her reasoning, it’s not a great advert for others to invest is it? It may in hindsight have been better to say nothing?

Good luck to you anyhow

Here is the link to the recording:-

https://www.valirx.com/news/valirx-agm-2023

Make your own calls....

@Goomer

AND i still say, IF THX ever get funded and pay VAL i will show my ars' in Poundland's window.

I wait as wait does, to be proved wrong. Actions speak louder than words IMO.

What's worse, is that with a little commercial acumen applied, VAL could have a) removed the exclusivity clause unless a payment made to retain it and b) spent the last two years with a funded party getting actual trials going rather than just still waiting on this two bit start up.

WOW, I'm in shock

The entire board got re-elected... speechless

Well good luck to you Adam if that's your dream team...

So we are in for more of the same then.... reap what you sow as they say.

I had Gerry down as an absolute certain bet to go, closely followed in votes by Kevin, Just shows you

PYC - Physiomics @Freddleboy but most of us got your drift

I still standby my view that Jim would be better off joining Valirx. SP was 2p yesterday and placing done at 1p. So in a nut shell they have £500k cash, £660k of Revenue and a market cap of £ 1.5m on the revised basis fully diluted.

Sooner markets start picking up the better

IF Operating loss is £3.36 million for Year and the Operational Update on 9th May confirmed that the Group's cash balance and debtor position as of 31 March 2023 was £690k and based on prior years, the Company expects to receive an R&D tax credit of not less than £600k before the end of H1.

By VERY rough calculation cash burn average is £ 280k pcm so assuming the tax credit lands in time, that gives us circa 4.6 months cash runway from 31st March 2023 i.e., lights out second week of August.

Even allowing for the recent improvements in trading, if they can pay staff salaries in August it will be a miracle? So why are we not seeing an RNS or any indication that a placing will take place shortly? Its 24th June today so we are talking 7 weeks max???

I am keen to take a position here as I like what they do, I still have concerns about the CAC but long term if they can find a way to break even the potential here is enormous, but I just can’t bring myself to go anywhere near the buy button with their financial position so uncertain.

Anyone know what’s going on? Or am I missing something regarding these financials declared?

Thanks

@Webbo502

Make any assumption you like about me, It matters not. This forum should be about the stock and not individuals.

You can refuse to accept this but I can 100% confirm that i want to see 201 in phase trials - i deeply care about this - end of. For me 201 was my principle reason for investing here. I thought my God if this works as per George, and they can get this into the market wouldn't that be something?

As you are aware @Webbo, i try to do as much DD as i can regarding anything i invest in, sure with Penny shares you just cant get it right all the time. Like i have said in the past, with many of these plays on the AIM often what they don't say is more important than what they do say.

Now i have no idea why VAL decided that THX was the best place for 201. Maybe in hindsight nobody else would take it? Suzy has never really said other than "she really likes working with them" BUT what i can confirm is that i was mega positive, was building on my position here and EVERYONE was jumping for joy at the prospect that 201 our flagship product was going to go to a major biotech on a deal. Even Adam was considering value potential for this product in the right hands ultimately on the market and shortly it was going to be finally entering trials.

Then the bombshell news landed, anyhow everything spiraled downwards from that day, as i see it, crap subsequent decisions IMO the majority of which all bleed from that one decision to go with THX.

We are now two years on and even now, 201 is nowhere near a trial, we are still waiting on THX. We are still waiting "unconcerned" for THX on an exclusive to get funded. How can that be right @Webbo?? Next to zero control over the deal either, they failed multiple times to meet deadlines and ultimately rather than take it in hand, VAL just remove the timelines. We should be two years down the line on trials now, not still waiting.

So forgive me, if when the rampers come out in full force, I'm not joining in. I don't share the excitement, i also cant understand why the board as a collective have made some of the other calls they made, why Gerry didn't suggest a raise at 30p? for example.

Anyhow, I am not going into anything else now, many points we have discussed to death now but you can claim i'm lower than a snakes belly if you like, say what you like but i am no fraud. I am interested in the AGM and the forward plans and live in hope that changes can be made to the board and point this ship on a better course going forwards.

For me, if 201 was given away to a well funded Biotech for FREE that would fund the trials and we only got paid on success, i would take that all day long over nothing happening and waiting what feels like forever for a start up to get funded. I hope this post explains my position?

We will see what happens next. Good luck to you.

Pork's

@HD

Nothing poultry about £8m value, it’s over 300% higher than it was April 21 with zero revenue in 15 years and raise 6 due shortly.

And you are mistaken about THX. IF they get funded and that’s a massive IF VAL get £1.3m in the first year less 6% to PYC and future milestones a) if trials are successful further down the line and b) moreover, THX can pay them out. And that’s not enough for half a years funding.

I wouldn’t hold your breath waiting for THX frankly.

Hoping that Suzy can draw a line shortly regarding THX and remove the exclusivity so negotiations elsewhere can start, albeit two years further on, sooner we can get it with a funded biotech to start trials to see if it can work the better.

In the meantime not long now until the AGM and we can see what the board and forward plans are going forwards

@Colbaltblue

LOL - you are not suggesting the Ramping Club might object....

Mind you, nothing wrong with flat let's in Devon, good solid long term investment for your family especially if you can buy with cash, good deals at the moment with those landlords over leveraged with mortgage debt.

Firstly, there is not some secret agenda to get a lower share price, the share price will reflect the actions of the BOD and take care of itself. This board is a forum to discuss the “stock” or at least should be but has been taken over by rampers as I see it and anyone who dares to challenge their view has their posts removed.

A number of posters have complained about the ROI but as I stated yesterday, I would argue that since Suzy started, the SP has actually gone from 3.5p April 21 to today 8p and in market capitalisation terms that’s an increase from £2.2m to £8m. So very good. Those that brought at higher highs are not so happy, but this is a penny share on the AIM and the Share price will always be volatile. The next placing will be at a level it can attract support at, it’s that simple and nothing discussed here can change that. Market conditions are ever changing.

Let’s face it everyone knows someone who has died of Cancer, its God dam awful, I have friends and family of my own that have passed on because of cancer, there is nothing worse. But my view is if you want to support a Cancer Charity donate to Cancer Research UK.

Money invested here is in an actual commercial business, Suzy is not working here for Charity, neither are the rest of the BOD, we are funding to pay for this and funding to pay Suzy over £160k odd a year to do the job right and as such you want that money invested wisely and want some solid progress. Some lose sight of that whilst others are miffed to put it mildly that they have not updated on certain progress when they say they will and in general not delivered results SH want to see over the last few years.

My own view is that the handling of 201 specifically was a disaster especially removing timelines. I said the other day and some picked up on it, I would rather 201 was given away for free to an established biotech with funds to get it into phase trials to see if it works or not and a milestone payment on success, than see us wait two years and counting IF the start up it was given to, can get funding or not. That decision is not helping anyone as I see it, I consider it a poor decision, sorry.

Decisions will be made at the AGM, forward plans specified, and we go from there. Let’s see.

In the meantime, @SeanCadman my view is that Stella is an incredibly smart and professional businesswomen that I highly respect, she will likely invest when the business is “stable”, and I would do the same in her position. She is not investing today, and neither is Suzy or any of the other board members because the business needs to be on stable grounds first.

That is business, its not personal and they list on the AIM market to get that support externally whilst they try and build the business. Some might not like that fact, but its how it is.

Yes removed because they didn’t like anything that disagrees with a pro ramp position.

@Freddleboy

So you just want to be in a ramping echo chamber then and remove comments that disagree - joke.

@G-Martin

In the demand zone, LMAO, how ridiculous

The only buyers are those down averaging or those desperate to try and hold the SP up at this artificial level. We have to see what the board looks like after the AGM, we might not have a ceo depending on how the votes go, we have 6 months cash runway to end of the year and 40% dilution about to hit us, if not 50% should the 10m options resolution also get over the line.

I would also point out that despite all the recent blunders and increased cash burn here, Suzy has in fact taken the mcap from £2.2m April 21 when she took over to now to £8m. Share price 3.5p to 8.5p .

I believe the risk profile looked better in April 21 when Suzy first took over to the risk profile today with a market cap three times higher. I totally back Stella regarding her stance of working to get the business stable - she is totally right and honest about the work ahead of them.

Will be interesting how events unfold for sure